Work

EA5142 adjuvant nivolumab in resected lung cancers (ANVIL): The newest study in the ALCHEMIST platform.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps8575

Authors: Jamie E. Chaft, Suzanne Eleanor Dahlberg, David E. Gerber, Geoffrey R. Oxnard, Shakun M. Malik, Charles B. Simone, Martin J. Edelman, John Heymach, Charles M. Rudin, Suresh S. Ramalingam

Institutions: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, The University of Texas Southwestern Medical Center, National Cancer Institute, Hospital of the University of Pennsylvania, Fox Chase Cancer Center, The University of Texas MD Anderson Cancer Center, Emory University, Winship Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2806283189

Cites:

Cited by: 12

Related to: 10